换一批
换一批Long-term outcomes of previously untreated myeloma patients: responses to induction chemotherapy and high-dose melphalan incorporated within a risk stratification model can help to direct the use of novel treatments.
第一作者：
Caroline L,Alvares
第一单位：
Haemato-oncology Unit, Royal Marsden Hospital, Sutton, Surrey, UK.
作者：
主题词
成年人(Adult);老年人(Aged);抗肿瘤药, 烷基化(Antineoplastic Agents, Alkylating);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);骨髓移植(Bone Marrow Transplantation);用药计划表(Drug Administration Schedule);随访研究(Follow-Up Studies);人类(Humans);美法仑(Melphalan);中年人(Middle Aged);多发性骨髓瘤(Multiple Myeloma);缓解诱导(Remission Induction);危险(Risk);存活率(Survival Rate);时间因素(Time Factors);治疗结果(Treatment Outcome)
DOI
10.1111/j.1365-2141.2005.05514.x
PMID
15916682
发布时间
2013-11-21
- 浏览106
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
